CAS: 1254507-01-1

GKT136901 HCl: Potent, selective NOX1/4 inhibitor, K i of 160/165 nM, combats diabetic complications, stroke, and inflammation.

GKT136901 is a potent, selective, and orally bioavailable small molecule that activates the G protein-coupled receptor GPR35. It has been shown to have minimal effect on other receptors. This agent has been shown to be an effective inhibitor of the bacterial enzyme phosphodiesterase 4 (PDE4) with IC50 values of 0.1 nM and 0.5 nM in human cells, respectively. It also inhibits the activity of the human PDE4D3 isoform with an IC50 value of 10 nM in vitro. GKT136901 hydrochloride is a potent and selective small molecule activator of the G protein coupled receptor, GPR35, which is known to regulate immune responses and inflammation. The agent has also been shown to inhibit the activity of a number of other proteins including phosphodiesterase 4 (PDE4) enzymes at low nanomolar concentrations, with selectivity for some isoforms over others